Neurobiology of Aging
Volume 29, Issue 1 , Pages 78-83 , January 2008

PPAR-γ Pro12Ala genotype and risk of cognitive decline in elders

  • K. Yaffe

      Affiliations

    • Department of Psychiatry and Neurology, University of California, San Francisco, CA, United States
    • Department of Epidemiology, University of California, San Francisco, CA, United States
    • San Francisco VA Medical Center, San Francisco, CA, United States
    • Corresponding Author InformationCorresponding author at: c/o University of California, San Francisco, P.O. Box 181, 4150 Clement Street, San Francisco, CA 94121, United States. Tel.: +1 415 221 4810; fax: +1 415 750 6641.
    • ,
  • A.M. Kanaya

      Affiliations

    • Department of Epidemiology, University of California, San Francisco, CA, United States
    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • K. Lindquist

      Affiliations

    • Department of Geriatrics, University of California, San Francisco, CA, United States
    • ,
  • W.C. Hsueh

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA, United States
    • ,
  • S.R. Cummings

      Affiliations

    • California Pacific Medical Center, San Francisco, CA, United States
    • ,
  • B. Beamer

      Affiliations

    • Department of Medicine, Johns Hopkins University, Baltimore, MD, United States
    • ,
  • A. Newman

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States
    • ,
  • C. Rosano

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, United States
    • ,
  • R. Li

      Affiliations

    • Center for Genomics and Bioinformatics, Department of Preventive Medicine, University of Tennessee Health Science Center, Memphis, TN, United States
    • ,
  • T. Harris

      Affiliations

    • Laboratory of Epidemiology, Demography, and Biometry, National Institute on Aging, Bethesda, MD, United States
    • ,
  • for the Health ABC Study

Received 15 May 2006 ,Revised 3 August 2006 ,Accepted 13 September 2006.

References 

  1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26(1):76–80
  2. Beamer BA, Yen CJ, Andersen RE, Muller D, Elahi D, Cheskin LJ, et al. Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations. Diabetes. 1998;47(11):1806–1808
  3. Beres CA, Baron A. Improved digit symbol substitution by older women as a result of extended practice. J Gerontol. 1981;36(5):591–597
  4. Bernardo A, Levi G, Minghetti L. Role of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its natural ligand 15-deoxy-Delta12, 14-prostaglandin J2 in the regulation of microglial functions. Eur J Neurosci. 2000;12(7):2215–2223
  5. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64–74
  6. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldiner AR, et al. The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord. 2000;24(3):391–393
  7. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. J Neurosci. 2000;20(2):558–567
  8. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. 2004;3(March (3)):169–178
  9. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 1998;20(3):284–287
  10. Ek J, Urhammer SA, Sorensen TI, Andersen T, Auwerx J, Pedersen O. Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men. Diabetologia. 1999;42(7):892–895
  11. Fornage M, Jacobs DR, Steffes MW, Gross MD, Bray MS, Schreiner PJ. Inverse effects of the PPAR(gamma)2 Pro12Ala polymorphism on measures of adiposity over 15 years in African Americans and Whites. The CARDIA study. Metabolism. 2005;54(7):910–917
  12. Grodstein F, Chen J, Wilson RS, Manson JE. Type 2 diabetes and cognitive function in community-dwelling elderly women. Diabetes Care. 2001;24(6):1060–1065
  13. Heneka MT, Klockgether T, Feinstein DL. Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci. 2000;20(18):6862–6867
  14. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545–548
  15. Kao WH, Coresh J, Shuldiner AR, Boerwinkle E, Bray MS, Brancati FL. Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. Diabetes. 2003;52(6):1568–1572
  16. Kielian T, Drew PD. Effects of peroxisome proliferator-activated receptor-gamma agonists on central nervous system inflammation. J Neurosci Res. 2003;71(3):315–325
  17. Kuller LH, Lopez OL, Newman A, Beauchamp NJ, Burke G, Dulberg C, et al. Risk factors for dementia in the cardiovascular health cognition study. Neuroepidemiology. 2003;22(1):13–22
  18. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem. 1995;270(22):12953–12956
  19. Luchsinger JA, Tang MX, Shea S, Mayeux R. Hyperinsulinemia and risk of Alzheimer disease. Neurology. 2004;63(7):1187–1192
  20. Luna-Medina R, Cortes-Canteli M, Alonso M, Santos A, Martinez A, Perez-Castillo A. Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem. 2005;280(22):21453–21462
  21. Masud S, Ye S. Effect of the peroxisome proliferator activated receptor-gamma gene Pro12Ala variant on body mass index: a meta-analysis. J Med Genet. 2003;40(10):773–780
  22. McKeigue PM, Carpenter JR, Parra EJ, Shriver MD. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet. 2000;64(Pt 2):171–186
  23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401
  24. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes. 2002;51(8):2341–2347
  25. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987;48(8):314–318
  26. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry. 2005;13(11):950–958
  27. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ. 2005;330(7504):1360
  28. Yaffe K, Blackwell T, Kanaya AM, Davidowitz N, Barrett-Connor E, Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology. 2004;63(4):658–663
  29. Yen CJ, Beamer BA, Negri C, Silver K, Brown KA, Yarnall DP, et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun. 1997;241(2):270–274

PII: S0197-4580(06)00341-1

doi: 10.1016/j.neurobiolaging.2006.09.010

Neurobiology of Aging
Volume 29, Issue 1 , Pages 78-83 , January 2008

Article Tools

* Image Usage & Resolution